Agilon Health, Inc. (NYSE:AGL) Receives Consensus Recommendation of "Hold" from Brokerages

Key Points

• Analysts have a consensus “Hold” on Agilon Health from 16 analysts (2 sell, 11 hold, 3 buy), with an average 1‑year price target of about $50.20.
• The company missed EPS in the most recent quarter (‑$0.46 vs. ‑$0.27 expected) despite a revenue beat, and still shows weak profitability (negative ROE of 120.82% and net margin of ‑6.6%), with analysts forecasting about ‑0.59 EPS for the year.
• Major hedge funds have materially increased positions—notably Goldman Sachs, AQR and CenterBook—indicating significant institutional buying even as fundamentals remain challenged.

Shares of Agilon Health, Inc. (NYSE:AGL - Get Free Report) have been given a consensus recommendation of "Hold" by the sixteen analysts that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $50.2045.

A number of analysts recently issued reports on AGL shares. Deutsche Bank Aktiengesellschaft set a $33.00 price target on shares of Agilon Health and gave the stock a "hold" rating in a research note on Thursday. Benchmark lifted their price target on shares of Agilon Health to $13.00 and gave the stock a "buy" rating in a research note on Thursday, April 2nd. Wells Fargo & Company lifted their price target on shares of Agilon Health from $25.00 to $37.50 and gave the stock an "overweight" rating in a research note on Friday, February 27th. Barclays dropped their price target on shares of Agilon Health from $25.00 to $12.50 and set an "underweight" rating for the company in a research note on Friday, February 27th. Finally, Weiss Ratings restated a "sell (e+)" rating on shares of Agilon Health in a research note on Wednesday, January 21st.

Agilon Health Stock Up 14.3%

Shares of NYSE:AGL opened at $21.74 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a fifty day simple moving average of $13.32 and a 200 day simple moving average of $17.85. The firm has a market cap of $360.62 million, a PE ratio of -0.92 and a beta of 0.33. Agilon Health has a 12-month low of $7.48 and a 12-month high of $144.25.

Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.19). The company had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.46 billion. Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%. On average, equities research analysts anticipate that Agilon Health will post -0.59 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

A number of hedge funds have recently added to or reduced their stakes in AGL. Goldman Sachs Group Inc. boosted its holdings in Agilon Health by 196.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company's stock worth $13,812,000 after purchasing an additional 13,283,930 shares during the period. AQR Capital Management LLC boosted its holdings in Agilon Health by 1,346.6% in the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company's stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the period. CenterBook Partners LP boosted its holdings in Agilon Health by 492.4% in the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company's stock worth $11,771,000 after purchasing an additional 9,499,012 shares during the period. North Peak Capital Management LLC boosted its holdings in Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company's stock worth $26,267,000 after purchasing an additional 3,715,460 shares during the period. Finally, Voleon Capital Management LP boosted its holdings in Agilon Health by 5,519.2% in the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company's stock worth $2,823,000 after purchasing an additional 2,692,259 shares during the period.

About Agilon Health

Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.